미국의 척추 수술용 AI 시장 규모, 점유율, 동향 분석 보고서 : 기능별, 용도별, 최종 용도별, 부문별 예측(2026-2033년)

U.S. AI in Spine Surgery Market Summary

The U.S. AI in spine surgery market size was estimated at USD 243.34 million in 2025 and is projected to reach USD 752.13 million by 2033, growing at a CAGR of 15.18% from 2026 to 2033. The increasing prevalence of degenerative spine conditions, the need for greater surgical precision, fewer revision surgeries, better implant positioning, and the widespread adoption of robotic-assisted surgical platforms and advanced navigation systems are significant factors contributing to market growth.

The U.S. has a high prevalence of degenerative spine conditions, such as spinal stenosis, spondylolisthesis, disc degeneration, and scoliosis. An aging population and high obesity rates have increased the need for spinal fusion and decompression procedures. Each year, the country performs over 900,000 spine surgeries, ranging from minimally invasive decompression and spinal cord stimulator placements to complex spinal deformity corrections and spinal cord tumor resections, according to data published in the PubMed Central Journal in August 2025. This large procedural volume supports the integration of AI technologies in spine surgery.

Moreover, the need for greater surgical precision, fewer revision surgeries, and better implant positioning is driving the adoption of AI-enabled robotic and navigation platforms in U.S. hospitals and ambulatory surgery centers. In addition, spine surgeons in the U.S. are early adopters of image-guided and data-driven technologies. AI enhances preoperative planning, intraoperative accuracy, and predictive analytics for patient selection. Hospitals leverage AI-enabled spine platforms to reduce complications, improve screw placement accuracy, and shorten operative times.

Moreover, the U.S. healthcare system has widespread adoption of robotic-assisted surgical platforms and advanced navigation systems. Major academic medical centers and large health systems actively invest in AI-integrated surgical technologies to enhance clinical outcomes and institutional competitiveness. For instance, in February 2026, Carlsmed announced the first aprevo Bilateral Posterior Lumbar Interbody Fusion (PLIF) procedure performed at the University of Colorado Hospital in Denver. The AI-planned, 3D-printed patient-specific implants expand the aprevo platform's versatility across lumbar approaches.

Healthcare systems are increasingly leveraging big data and predictive analytics to personalize treatment pathways. AI tools in spine surgery enable preoperative simulation, implant selection optimization, and prediction of complication risk based on patient-specific anatomical and clinical data. Precision medicine initiatives and integration with electronic health records enhance AI model performance. Surgeons use AI-generated insights to improve procedural planning and alignment strategies. The growing emphasis on data-driven clinical decision-making supports widespread integration of AI technologies into spine surgery workflows. For instance, in November 2025, Proprio, an AI-powered surgical intelligence company, partnered with the Harms Study Group to create a research collaborative linking real-time intraoperative data from Proprio's Paradigm platform with HSG's global spine deformity outcomes registry. The integrated dataset is likely to automate data capture, enhance registry quality, and support multicenter AI-driven studies to optimize pediatric spine surgery.

U.S. AI in Spine Surgery Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. AI in spine surgery market report based on functionality, application, and end use:

• Functionality Outlook (Revenue, USD Million, 2021 - 2033)
• Pre-op planning & personalization (alignment/planning, patient-specific constructs)
• Intraoperation guidance / navigation / AR / digital execution
• Diagnostic decision support
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Spinal Fusion
• Microdiscectomy
• Laminectomy
• Laminotomy
• Lumbar decompression (non-fusion)
• Other
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
• Ambulatory Surgery Centers (ASCs)
• Orthopedic Centers
• Others

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definitions
  • 1.2.1. Functionality Segment
  • 1.2.2. Application Segment
  • 1.2.3. End Use
• 1.3. Information analysis
  • 1.3.1. Market formulation & data visualization
• 1.4. Data validation & publishing
• 1.5. Information Procurement
  • 1.5.1. Primary Research
• 1.6. Information or Data Analysis
• 1.7. Market Formulation & Validation
• 1.8. Market Model
• 1.9. Total Market: CAGR Calculation
• 1.10. Objectives
  • 1.10.1. Objective 1
  • 1.10.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Insights Landscape

Chapter 3. U.S. AI in Spine Surgery Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook.
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
  • 3.2.2. Market restraint analysis
  • 3.2.3. Market opportunity analysis
  • 3.2.4. Market challenges analysis
• 3.3. AI in Spine Surgery Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape
    • 3.3.2.4. Environmental Landscape
    • 3.3.2.5. Legal Landscape
    • 3.3.2.6. Social Landscape

Chapter 4. U.S. AI in Spine Surgery Market: Functionality Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. U.S. AI in Spine Surgery Market Functionality Movement Analysis
• 4.3. U.S. AI in Spine Surgery Market Size & Trend Analysis, by Functionality, 2021 to 2033 (USD Million)
• 4.4. Pre-op Planning & Personalization
  • 4.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 4.5. Intraoperation Guidance / Navigation / AR / Digital Execution
  • 4.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 4.6. Diagnostic Decision Support
  • 4.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 5. U.S. AI in Spine Surgery Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. U.S. AI in Spine Surgery Market Application Movement Analysis
• 5.3. U.S. AI in Spine Surgery Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
• 5.4. Spinal Fusion
  • 5.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 5.5. Microdiscectomy
  • 5.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 5.6. Laminectomy
  • 5.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 5.7. Laminotomy
  • 5.7.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 5.8. Lumbar decompression (non-fusion)
  • 5.8.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 5.9. Other
  • 5.9.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 6. AI in Spine Surgery Market: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. U.S. AI in Spine Surgery Market End Use Movement Analysis
• 6.3. U.S. AI in Spine Surgery Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
• 6.4. Hospitals
  • 6.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 6.5. Ambulatory Surgery Centers (ASCs)
  • 6.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 6.6. Orthopedic Centers
  • 6.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
• 6.7. Others
  • 6.7.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Company/Competition Categorization
• 7.2. Strategy Mapping
• 7.3. Company Market Position Analysis, 2025
• 7.4. Company Profiles/Listing
  • 7.4.1. Globus Medical
    • 7.4.1.1. Company overview
    • 7.4.1.2. Financial performance
    • 7.4.1.3. Product benchmarking
    • 7.4.1.4. Strategic initiatives
  • 7.4.2. Medtronic
    • 7.4.2.1. Company overview
    • 7.4.2.2. Financial performance
    • 7.4.2.3. Product benchmarking
    • 7.4.2.4. Strategic initiatives
  • 7.4.3. Orthofix (7D Surgical tech)
    • 7.4.3.1. Company overview
    • 7.4.3.2. Financial performance
    • 7.4.3.3. Product benchmarking
    • 7.4.3.4. Strategic initiatives
  • 7.4.4. Augmedics
    • 7.4.4.1. Company overview
    • 7.4.4.2. Financial performance
    • 7.4.4.3. Product benchmarking
    • 7.4.4.4. Strategic initiatives
  • 7.4.5. DePuy Synthes (Johnson & Johnson MedTech)
    • 7.4.5.1. Company overview
    • 7.4.5.2. Financial performance
    • 7.4.5.3. Product benchmarking
    • 7.4.5.4. Strategic initiatives
  • 7.4.6. Carlsmed
    • 7.4.6.1. Company overview
    • 7.4.6.2. Financial performance
    • 7.4.6.3. Product benchmarking
    • 7.4.6.4. Strategic initiatives
  • 7.4.7. Surgical Theater, Inc.
    • 7.4.7.1. Company overview
    • 7.4.7.2. Financial performance
    • 7.4.7.3. Product benchmarking
    • 7.4.7.4. Strategic initiatives